Treatment possibilities for psychosis in Parkinson's disease with an emphasis on the newly approved drug: Pimavanserin

Majláth Zsófia and Obál Izabella and Vécsei László: Treatment possibilities for psychosis in Parkinson's disease with an emphasis on the newly approved drug: Pimavanserin.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 16 (3). pp. 234-243. ISSN 1871-5273 (2017)

[thumbnail of 2017._Majlath_Z._Pimavanserin___CNSND_MS_u.pdf]
Preview
Text
2017._Majlath_Z._Pimavanserin___CNSND_MS_u.pdf - Accepted Version

Download (466kB) | Preview
Creators:
Majláth Zsófia MTMT
Obál Izabella MTMT
Vécsei László MTMT
Item Type: Journal Article
Journal or Publication Title: CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
Date: 2017
Volume: 16
Number: 3
Page Range: pp. 234-243
ISSN: 1871-5273
Publisher: Bentham Science Publishers Ltd.
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 3253312
DOI azonosító: https://doi.org/10.2174/1871527315666161006104347
Date Deposited: 2017. Oct. 10. 10:32
Last Modified: 2019. Nov. 07. 10:46
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12072
Web of Science® Times Cited: 2 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year